| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Axitinib | FIMM | pan-cancer | AAC | -0.024 | 0.9 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.0071 | 0.9 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | -0.0043 | 0.9 |